Research
Open Access
Patient empowerment brochures to increase gabapentinoid deprescribing: protocol for the prospective, controlled before-and-after GABA-WHY trial
Jerome Williams, Marc-Alexandre Gingras, Robert Dubé, Todd C. Lee and Emily G. McDonald
July 12, 2022 10 (3) E652-E656; DOI: https://doi.org/10.9778/cmajo.20210302
Jerome Williams
Department of Medicine (Williams, Gingras, Dubé, Lee, McDonald), McGill University; Clinical Practice Assessment Unit (Lee, McDonald), Department of Medicine, McGill University Health Centre, Montréal, Que.
BScMarc-Alexandre Gingras
Department of Medicine (Williams, Gingras, Dubé, Lee, McDonald), McGill University; Clinical Practice Assessment Unit (Lee, McDonald), Department of Medicine, McGill University Health Centre, Montréal, Que.
MD MScRobert Dubé
Department of Medicine (Williams, Gingras, Dubé, Lee, McDonald), McGill University; Clinical Practice Assessment Unit (Lee, McDonald), Department of Medicine, McGill University Health Centre, Montréal, Que.
MScTodd C. Lee
Department of Medicine (Williams, Gingras, Dubé, Lee, McDonald), McGill University; Clinical Practice Assessment Unit (Lee, McDonald), Department of Medicine, McGill University Health Centre, Montréal, Que.
MD MPHEmily G. McDonald
Department of Medicine (Williams, Gingras, Dubé, Lee, McDonald), McGill University; Clinical Practice Assessment Unit (Lee, McDonald), Department of Medicine, McGill University Health Centre, Montréal, Que.
MDCM MSc
Submit a Response to This Article
Jump to comment:
No Responses have been published for this article.
In this issue
Article tools
Patient empowerment brochures to increase gabapentinoid deprescribing: protocol for the prospective, controlled before-and-after GABA-WHY trial
Jerome Williams, Marc-Alexandre Gingras, Robert Dubé, Todd C. Lee, Emily G. McDonald
Jul 2022, 10 (3) E652-E656; DOI: 10.9778/cmajo.20210302
Related Articles
Cited By...
- No citing articles found.